Chemours annual revenue
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Chemours Revenue Growth & History (CC)
Chemours reported $5.81B in revenue for fiscal 2025, an increase of 0.45% from the previous fiscal year.
View full Chemours company overviewChemours annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.81B | $26.0M | +0.45% |
| 2024 | 2024-12-31 | $5.78B | −$296.0M | −4.87% |
| 2023 | 2023-12-31 | $6.08B | −$753.0M | −11.02% |
| 2022 | 2022-12-31 | $6.83B | $486.0M | +7.66% |
| 2021 | 2021-12-31 | $6.34B | $1.38B | +27.69% |
| 2020 | 2020-12-31 | $4.97B | −$557.0M | −10.08% |
| 2019 | 2019-12-31 | $5.53B | −$1.11B | −16.75% |
| 2018 | 2018-12-31 | $6.64B | $455.0M | +7.36% |
| 2017 | 2017-12-31 | $6.18B | $783.0M | +14.50% |
| 2016 | 2016-12-31 | $5.40B | −$317.0M | −5.54% |
| 2015 | 2015-12-31 | $5.72B | −$715.0M | −11.12% |
| 2014 | 2014-12-31 | $6.43B | −$427.0M | −6.23% |
| 2013 | 2013-12-31 | $6.86B | — | — |
Chemours quarterly revenue
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.59B | −$24.0M | −1.49% |
| Q1 2026 | 2026-03-31 | $1.38B | $13.0M | +0.95% |
| Q4 2025 | 2025-12-31 | $1.33B | −$30.0M | −2.21% |
| Q3 2025 | 2025-09-30 | $1.50B | −$13.0M | −0.86% |
| Q2 2025 | 2025-06-30 | $1.61B | $61.0M | +3.93% |
| Q1 2025 | 2025-03-31 | $1.37B | $6.0M | +0.44% |
| Q4 2024 | 2024-12-31 | $1.36B | −$9.0M | −0.66% |
| Q3 2024 | 2024-09-30 | $1.51B | $7.0M | +0.47% |
| Q2 2024 | 2024-06-30 | $1.55B | −$106.0M | −6.39% |
| Q1 2024 | 2024-03-31 | $1.36B | −$187.0M | −12.07% |
| Q4 2023 | 2023-12-31 | $1.37B | $30.0M | +2.24% |
| Q3 2023 | 2023-09-30 | $1.50B | −$276.0M | −15.53% |
| Q2 2023 | 2023-06-30 | $1.66B | −$255.0M | −13.32% |
| Q1 2023 | 2023-03-31 | $1.55B | −$215.0M | −12.19% |
| Q4 2022 | 2022-12-31 | $1.34B | −$236.0M | −14.99% |
| Q3 2022 | 2022-09-30 | $1.78B | $97.0M | +5.77% |
| Q2 2022 | 2022-06-30 | $1.92B | $260.0M | +15.71% |
| Q1 2022 | 2022-03-31 | $1.76B | $328.0M | +22.84% |
| Q4 2021 | 2021-12-31 | $1.57B | $236.0M | +17.64% |
| Q3 2021 | 2021-09-30 | $1.68B | $447.0M | +36.25% |
| Q2 2021 | 2021-06-30 | $1.66B | $562.0M | +51.42% |
| Q1 2021 | 2021-03-31 | $1.44B | $131.0M | +10.04% |
| Q4 2020 | 2020-12-31 | $1.34B | −$15.0M | −1.11% |
| Q3 2020 | 2020-09-30 | $1.23B | −$157.0M | −11.29% |
| Q2 2020 | 2020-06-30 | $1.09B | −$315.0M | −22.37% |
| Q1 2020 | 2020-03-31 | $1.30B | −$71.0M | −5.16% |
| Q4 2019 | 2019-12-31 | $1.35B | −$111.0M | −7.58% |
| Q3 2019 | 2019-09-30 | $1.39B | −$238.0M | −14.62% |
| Q2 2019 | 2019-06-30 | $1.41B | −$408.0M | −22.47% |
| Q1 2019 | 2019-03-31 | $1.38B | −$354.0M | −20.46% |
| Q4 2018 | 2018-12-31 | $1.46B | −$111.0M | −7.05% |
| Q3 2018 | 2018-09-30 | $1.63B | $44.0M | +2.78% |
| Q2 2018 | 2018-06-30 | $1.82B | $228.0M | +14.36% |
| Q1 2018 | 2018-03-31 | $1.73B | $293.0M | +20.39% |
| Q4 2017 | 2017-12-31 | $1.57B | $253.0M | +19.14% |
| Q3 2017 | 2017-09-30 | $1.58B | $186.0M | +13.30% |
| Q2 2017 | 2017-06-30 | $1.59B | $205.0M | +14.82% |
| Q1 2017 | 2017-03-31 | $1.44B | $140.0M | +10.79% |
| Q4 2016 | 2016-12-31 | $1.32B | −$38.0M | −2.79% |
| Q3 2016 | 2016-09-30 | $1.40B | −$88.0M | −5.92% |
| Q2 2016 | 2016-06-30 | $1.38B | −$125.0M | −8.29% |
| Q1 2016 | 2016-03-31 | $1.30B | −$66.0M | −4.84% |
| Q4 2015 | 2015-12-31 | $1.36B | −$189.0M | −12.20% |
| Q3 2015 | 2015-09-30 | $1.49B | −$147.0M | −9.00% |
| Q2 2015 | 2015-06-30 | $1.51B | −$176.0M | −10.45% |
| Q1 2015 | 2015-03-31 | $1.36B | −$206.0M | −13.13% |
| Q4 2014 | 2014-12-31 | $1.55B | — | — |
| Q3 2014 | 2014-09-30 | $1.63B | — | — |
| Q2 2014 | 2014-06-30 | $1.68B | — | — |
| Q1 2014 | 2014-03-31 | $1.57B | — | — |
Chemours revenue growth trends
Over the last five reported fiscal years, revenue grew from $4.97B to $5.81B, a compound annual growth rate of 3.17%. Chemours's latest reported quarter, Q2 2026, generated $1.59B in revenue, a decrease of 1.49% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...
